InvestorsHub Logo
Followers 62
Posts 1507
Boards Moderated 0
Alias Born 01/31/2014

Re: biosectinvestor post# 670355

Tuesday, 02/06/2024 12:42:16 PM

Tuesday, February 06, 2024 12:42:16 PM

Post# of 696939
Biosectinvestor, I do remember you showing that Flaskworks would not require an additional clinical trial for approval as long as comparability was done prior to regulatory approval. I believe people will again be surprised that, in the end NWBO is getting everything done right. Thanks again for this informative post!
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News